Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF

被引:2
|
作者
Orvieto, Raoul [1 ,2 ,3 ]
机构
[1] Chaim Sheba Med Ctr, Dept Obstet & Gynecol, Ramat Gan, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[3] Tel Aviv Univ, Sackler Fac Med, Tarnesby Tarnowski Chair Family Planning & Fertil, Tel Aviv, Israel
关键词
ANDROGEN; HORMONE;
D O I
10.1186/s12958-023-01069-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ovarian stimulation (OS) is one of the key factors in the success of in vitro fertilization-embryo transfer (IVF-ET), by enabling the recruitment of numerous healthy fertilizable oocytes and, thereby, multiple embryos. The Stop GnRH-agonist/GnRH-antagonist (GnRH-ag/GnRH-ant), which offers all the advantages of using long suppressive GnRH-ag, with GnRH-ant, is in my opinion a valuable addition to the armamentarium of OS protocols. It allows cycle programming, better follicular synchronization and offers successful outcome in a variety of challenging cases such as poor responders, Poseidon group 4 poor prognosis patients, those with elevated peak progesterone (P) serum levels, poor embryo quality or repeated IVF failures.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF
    Raoul Orvieto
    Reproductive Biology and Endocrinology, 21
  • [2] GNRH-AGONIST SHORT PROTOCOL VERSUS GNRH-ANTAGONIST FOR OVARIAN STIMULATION IN IVF.
    Taylor, J. J.
    FERTILITY AND STERILITY, 2014, 102 (03) : E107 - E107
  • [3] GnRH-Agonist Ovulation Trigger in Patients Undergoing Controlled Ovarian Hyperstimulation for IVF with Stop GnRH-Agonist Combined with Multidose GnRH-Antagonist Protocol
    Orvieto, Raoul
    Nahum, Ravit
    Zohav, Efraim
    Liberty, Gad
    Anteby, Eyal Y.
    Meltcer, Simion
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2021, 86 (05) : 427 - 431
  • [4] Similar outcome for cryopreserved embryo transfer following GnRH-antagonist/GnRH-agonist, GnRH-antagonist/HCG or long protocol ovarian stimulation
    Eldar-Geva, Talia
    Zylber-Haran, Edit
    Babayof, Rachel
    Halevy-Shalem, Tamar
    Ben-Chetrit, Avraharn
    Tsafrir, Avi
    Varshaver, Irit
    Brooks, Baruch
    Margalioth, Ehud J.
    REPRODUCTIVE BIOMEDICINE ONLINE, 2007, 14 (02) : 148 - 154
  • [5] A PROSPECTIVE RANDOMISED STUDY COMPARING A GNRH-ANTAGONIST VERSUS A GNRH-AGONIST SHORT PROTOCOL FOR OVARIAN STIMULATION IN PATIENTS REFERRED FOR IVF
    Gordts, S.
    Puttemans, P.
    Campo, R.
    Valkenburg, M.
    Gordts, S.
    FERTILITY AND STERILITY, 2011, 96 (03) : S176 - S176
  • [6] A prospective randomised study comparing a GnRH-antagonist versus a GnRH-agonist short protocol for ovarian stimulation in patients referred for IVF
    Gordts, S.
    Van Turnhout, C.
    Campo, R.
    Puttemans, P.
    Valkenburg, M.
    Gordts, S.
    FACTS VIEWS AND VISION IN OBGYN, 2012, 4 (02): : 82 - 87
  • [7] GnRH-agonist ovulation trigger in patients undergoing controlled ovarian hyperstimulation for IVF with ultrashort flare GnRH-agonist combined with multidose GnRH-antagonist protocol
    Orvieto, Raoul
    Nahum, Ravit
    Zohav, Efraim
    Liberty, Gad
    Anteby, Eyal Y.
    Meltcer, Simion
    GYNECOLOGICAL ENDOCRINOLOGY, 2013, 29 (01) : 51 - 53
  • [8] Stop GnRH-Agonist Combined With Multiple-Dose GnRH-Antagonist Protocol for Patients With "Genuine" Poor Response Undergoing Controlled Ovarian Hyperstimulation for IVF
    Orvieto, Raoul
    Kirshenbaum, Michal
    Galiano, Valentina
    Elkan-Miller, Tal
    Zilberberg, Eran
    Haas, Jigal
    Nahum, Ravit
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [9] GnRH-agonist versus GnRH-antagonist in elective single embryo transfer IVF cycles
    Fatemi, H. Mousavi
    Papanikolaou, E. G.
    Tournaye, H.
    Camus, M.
    Verpoest, W.
    Donoso, P.
    Van der Elst, J.
    Devroey, P.
    HUMAN REPRODUCTION, 2007, 22 : I5 - I5
  • [10] GnRH agonist stop antagonist protocol versus GnRH antagonist protocol in ovarian poor responders undergoing IVF
    Khezri, Atefeh
    Kashani, Ladan
    Moini, Ashraf
    Mojtahedi, Maryam Farid
    Yamini, Nazila
    Ataee, Mina
    REVISTA LATINOAMERICANA DE HIPERTENSION, 2022, 17 (01): : 46 - 52